Scholarly Works - Book sections
Book section
·
January 1, 2020
Antibody-mediated rejection (AMR) is a barrier to successful long-term xenograft survival. We compared AMR in kidney xenotransplantation to sensitized kidney allotransplantation in a nonhuman primate model. With conventional CNI-based immunosuppressive mai ...
Full text
Cite
Book section
·
January 1, 2019
Living donor kidney transplants constitute between 10% and 50% of annual kidney transplant volume worldwide. This chapter presents the history of living donation through the modern-day approach to living donation, with a focus on evolving paradigms of what ...
Full text
Cite
Book section
·
January 1, 2019
This chapter reviews outcomes of kidney transplantation using data derived from surveillance and registry data from the United States, Europe, Australia and New Zealand, in addition to data from individual transplant center reports and multicenter trial da ...
Full text
Cite
Book section
·
January 1, 2014
The field of soLid organ transplantation has rapidly evolved into the treatment of choice for many end-stage organ illnesses. Much of this evolution is attributable to significantly improved short-term outcomes resulting from successful immunosuppressive t ...
Full text
Cite
Book section
·
January 1, 2014
Liver transplantation is a technically demanding procedure that leaves little room for error. The surgical techniques of liver transplantation have evolved dramatically over the past 30 years, with striking improvements in outcomes. These improvements have ...
Full text
Cite
Book section
·
April 19, 2012
National registry data indicate a trend towards increasing use of lymphocyte-depleting antibody induction therapy into immunosuppressive regimens for solid organ transplantation. Depletional induction has been shown to reduce the risk of early acute reject ...
Full text
Cite
Book section
·
December 1, 2008
The success of many modern medical therapies is intimately tied to the success of vascular access. Hemodialysis for renal failure, chemotherapy for cancer, hyperalimentation for nutritional support, plasmapheresis for autoimmune disease, central pressure m ...
Full text
Cite
Book section
·
December 1, 2008
In 2002 in the United States, 431,281 patients received treatment for end-stage renal disease (ESRD), including 308,910 on dialysis and 122,374 with a functioning renal transplant.1 The prevalence of ESRD is increasing at an annual rate of 4%, down from 9% ...
Full text
Cite
Book section
·
October 9, 2006
Cite
https://orcid.org/0000-0002-1625-385X